
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The RNA-binding protein ESRP1 promotes human colorectal cancer progression
Sharmila Fagoonee, Gabriele Picco, Francesca Orso, et al.
Oncotarget (2016) Vol. 8, Iss. 6, pp. 10007-10024
Open Access | Times Cited: 61
Sharmila Fagoonee, Gabriele Picco, Francesca Orso, et al.
Oncotarget (2016) Vol. 8, Iss. 6, pp. 10007-10024
Open Access | Times Cited: 61
Showing 1-25 of 61 citing articles:
RNA-Binding Proteins in Cancer: Old Players and New Actors
Bruno Pereira, Marc Billaud, Raquel Almeida
Trends in cancer (2017) Vol. 3, Iss. 7, pp. 506-528
Closed Access | Times Cited: 663
Bruno Pereira, Marc Billaud, Raquel Almeida
Trends in cancer (2017) Vol. 3, Iss. 7, pp. 506-528
Closed Access | Times Cited: 663
Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories
Clarissa Gerhäuser, Francesco Favero, Thomas S. Risch, et al.
Cancer Cell (2018) Vol. 34, Iss. 6, pp. 996-1011.e8
Open Access | Times Cited: 250
Clarissa Gerhäuser, Francesco Favero, Thomas S. Risch, et al.
Cancer Cell (2018) Vol. 34, Iss. 6, pp. 996-1011.e8
Open Access | Times Cited: 250
Cancer the‘RBP’eutics–RNA-binding proteins as therapeutic targets for cancer
Shakur Mohibi, Xinbin Chen, Jin Zhang
Pharmacology & Therapeutics (2019) Vol. 203, pp. 107390-107390
Open Access | Times Cited: 156
Shakur Mohibi, Xinbin Chen, Jin Zhang
Pharmacology & Therapeutics (2019) Vol. 203, pp. 107390-107390
Open Access | Times Cited: 156
circCAMSAP1 Promotes Tumor Growth in Colorectal Cancer via the miR-328-5p/E2F1 Axis
Chi Zhou, Hua-shan Liu, Feng-Wei Wang, et al.
Molecular Therapy (2019) Vol. 28, Iss. 3, pp. 914-928
Open Access | Times Cited: 127
Chi Zhou, Hua-shan Liu, Feng-Wei Wang, et al.
Molecular Therapy (2019) Vol. 28, Iss. 3, pp. 914-928
Open Access | Times Cited: 127
Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer
Mohit Kumar Jolly, Bogdan-Tiberius Preca, S. C. Tripathi, et al.
APL Bioengineering (2018) Vol. 2, Iss. 3
Open Access | Times Cited: 85
Mohit Kumar Jolly, Bogdan-Tiberius Preca, S. C. Tripathi, et al.
APL Bioengineering (2018) Vol. 2, Iss. 3
Open Access | Times Cited: 85
Erratum: ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells
Hui‐Yun Jeong, Jinil Han, Seung‐Hun Lee, et al.
Oncogenesis (2017) Vol. 6, Iss. 11, pp. e391-e391
Open Access | Times Cited: 62
Hui‐Yun Jeong, Jinil Han, Seung‐Hun Lee, et al.
Oncogenesis (2017) Vol. 6, Iss. 11, pp. e391-e391
Open Access | Times Cited: 62
HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness
Jessica Ho, Federico Di Tullio, Megan Schwarz, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 43
Jessica Ho, Federico Di Tullio, Megan Schwarz, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 43
Circ-NOLC1 promotes epithelial ovarian cancer tumorigenesis and progression by binding ESRP1 and modulating CDK1 and RhoA expression
Shuo Chen, Wu Wu, Qian-hui Li, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 41
Shuo Chen, Wu Wu, Qian-hui Li, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 41
Circular RNAs as the pivotal regulators of epithelial-mesenchymal transition in gastrointestinal tumor cells
Reihaneh Alsadat Mahmoudian, Iman Akhlaghipour, Malihe Lotfi, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154472-154472
Closed Access | Times Cited: 16
Reihaneh Alsadat Mahmoudian, Iman Akhlaghipour, Malihe Lotfi, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154472-154472
Closed Access | Times Cited: 16
Post-transcriptional Regulation of Colorectal Cancer: A Focus on RNA-Binding Proteins
Jennyfer M. García‐Cárdenas, Santiago Guerrero, Andrés López‐Cortés, et al.
Frontiers in Molecular Biosciences (2019) Vol. 6
Open Access | Times Cited: 46
Jennyfer M. García‐Cárdenas, Santiago Guerrero, Andrés López‐Cortés, et al.
Frontiers in Molecular Biosciences (2019) Vol. 6
Open Access | Times Cited: 46
Circ_0092367 Inhibits EMT and Gemcitabine Resistance in Pancreatic Cancer via Regulating the miR-1206/ESRP1 Axis
Shuo Yu, Min Wang, Hang Zhang, et al.
Genes (2021) Vol. 12, Iss. 11, pp. 1701-1701
Open Access | Times Cited: 39
Shuo Yu, Min Wang, Hang Zhang, et al.
Genes (2021) Vol. 12, Iss. 11, pp. 1701-1701
Open Access | Times Cited: 39
ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cellsThis article has been corrected since Advance Online Publication and an erratum is also printed in this issue
Hui‐Yun Jeong, Jinil Han, Su-Heon Lee, et al.
Oncogenesis (2017) Vol. 6, Iss. 10, pp. e389-e389
Open Access | Times Cited: 48
Hui‐Yun Jeong, Jinil Han, Su-Heon Lee, et al.
Oncogenesis (2017) Vol. 6, Iss. 10, pp. e389-e389
Open Access | Times Cited: 48
RBP EIF2S2 Promotes Tumorigenesis and Progression by Regulating MYC-Mediated Inhibition via FHIT-Related Enhancers
Jiwei Zhang, Shengli Li, Ling Zhang, et al.
Molecular Therapy (2020) Vol. 28, Iss. 4, pp. 1105-1118
Open Access | Times Cited: 39
Jiwei Zhang, Shengli Li, Ling Zhang, et al.
Molecular Therapy (2020) Vol. 28, Iss. 4, pp. 1105-1118
Open Access | Times Cited: 39
Underlying mechanisms of epithelial splicing regulatory proteins in cancer progression
Ying Liu, Yiwen Li, Chengcheng Du, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 11, pp. 1539-1556
Closed Access | Times Cited: 21
Ying Liu, Yiwen Li, Chengcheng Du, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 11, pp. 1539-1556
Closed Access | Times Cited: 21
<p>LncRNA EMX2OS, Regulated by TCF12, Interacts with FUS to Regulate the Proliferation, Migration and Invasion of Prostate Cancer Cells Through the cGMP-PKG Signaling Pathway</p>
Zhiqiang Wang, Chaowei Zhang, Junkai Chang, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 7045-7056
Open Access | Times Cited: 31
Zhiqiang Wang, Chaowei Zhang, Junkai Chang, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 7045-7056
Open Access | Times Cited: 31
DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1
Qiong Wu, Jiali Ma, Wenying Meng, et al.
Cancer Biology & Therapy (2019) Vol. 21, Iss. 1, pp. 17-25
Open Access | Times Cited: 30
Qiong Wu, Jiali Ma, Wenying Meng, et al.
Cancer Biology & Therapy (2019) Vol. 21, Iss. 1, pp. 17-25
Open Access | Times Cited: 30
Effective combination of biocompatible zinc oxide nanocrystals and high-energy shock waves for the treatment of colorectal cancer
Luisa Racca, Giada Rosso, Marco Carofiglio, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Luisa Racca, Giada Rosso, Marco Carofiglio, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
MYC Regulates α6 Integrin Subunit Expression and Splicing Under Its Pro-Proliferative ITGA6A Form in Colorectal Cancer Cells
Jean‐François Groulx, Salah Boudjadi, Jean‐François Beaulieu
Cancers (2018) Vol. 10, Iss. 2, pp. 42-42
Open Access | Times Cited: 28
Jean‐François Groulx, Salah Boudjadi, Jean‐François Beaulieu
Cancers (2018) Vol. 10, Iss. 2, pp. 42-42
Open Access | Times Cited: 28
Comparative transcriptome analysis of endemic and epidemic Kaposi’s sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis
Salum J. Lidenge, Andrew V. Kossenkov, For Yue Tso, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 7, pp. e1008681-e1008681
Open Access | Times Cited: 24
Salum J. Lidenge, Andrew V. Kossenkov, For Yue Tso, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 7, pp. e1008681-e1008681
Open Access | Times Cited: 24
ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling
Meng Zheng, Yuchun Niu, Junguo Bu, et al.
Aging (2021) Vol. 13, Iss. 3, pp. 3554-3572
Open Access | Times Cited: 23
Meng Zheng, Yuchun Niu, Junguo Bu, et al.
Aging (2021) Vol. 13, Iss. 3, pp. 3554-3572
Open Access | Times Cited: 23
E2F1 and epigenetic modifiers orchestrate breast cancer progression by regulating oxygen-dependent ESRP1 expression
Cheemala Ashok, Neha Ahuja, Subhashis Natua, et al.
Oncogenesis (2021) Vol. 10, Iss. 8
Open Access | Times Cited: 21
Cheemala Ashok, Neha Ahuja, Subhashis Natua, et al.
Oncogenesis (2021) Vol. 10, Iss. 8
Open Access | Times Cited: 21
Prognostic role of TSPAN1, KIAA1324 and ESRP1 in prostate cancer
Melissa Stinnesbeck, Anna Kristiansen, Jörg Ellinger, et al.
Apmis (2021) Vol. 129, Iss. 4, pp. 204-212
Open Access | Times Cited: 19
Melissa Stinnesbeck, Anna Kristiansen, Jörg Ellinger, et al.
Apmis (2021) Vol. 129, Iss. 4, pp. 204-212
Open Access | Times Cited: 19
ACLY alternative splicing correlates with cancer phenotypes
Julianna Supplee, Hayley C. Affronti, Richard Duan, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 7, pp. 107418-107418
Open Access | Times Cited: 2
Julianna Supplee, Hayley C. Affronti, Richard Duan, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 7, pp. 107418-107418
Open Access | Times Cited: 2
Regulation of splicing and circularisation of RNA in epithelial mesenchymal plasticity
Daniel Neumann, Gregory J. Goodall, Philip A. Gregory
Seminars in Cell and Developmental Biology (2017) Vol. 75, pp. 50-60
Open Access | Times Cited: 23
Daniel Neumann, Gregory J. Goodall, Philip A. Gregory
Seminars in Cell and Developmental Biology (2017) Vol. 75, pp. 50-60
Open Access | Times Cited: 23
Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT
Yellamandayya Vadlamudi, Debasish Kumar Dey, Sun Chul Kang
Current Cancer Drug Targets (2020) Vol. 20, Iss. 9, pp. 654-665
Closed Access | Times Cited: 19
Yellamandayya Vadlamudi, Debasish Kumar Dey, Sun Chul Kang
Current Cancer Drug Targets (2020) Vol. 20, Iss. 9, pp. 654-665
Closed Access | Times Cited: 19